Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit biogenesis (GO:0042274) | 5.30536015 |
2 | viral transcription (GO:0019083) | 4.89612906 |
3 | translational termination (GO:0006415) | 4.55484887 |
4 | neutrophil activation involved in immune response (GO:0002283) | 4.27179570 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.98359525 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.98359525 |
7 | modulation by symbiont of host immune response (GO:0052553) | 3.98359525 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.98359525 |
9 | modulation by symbiont of host defense response (GO:0052031) | 3.98359525 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.98359525 |
11 | translational elongation (GO:0006414) | 3.96234483 |
12 | viral life cycle (GO:0019058) | 3.90297793 |
13 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.79506618 |
14 | maturation of SSU-rRNA (GO:0030490) | 3.77470366 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75416769 |
16 | negative regulation of cell killing (GO:0031342) | 3.75416769 |
17 | protein targeting to ER (GO:0045047) | 3.74416287 |
18 | ribosomal small subunit assembly (GO:0000028) | 3.69160726 |
19 | cotranslational protein targeting to membrane (GO:0006613) | 3.69159074 |
20 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.66868451 |
21 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.63953623 |
22 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.58850470 |
23 | protein localization to endoplasmic reticulum (GO:0070972) | 3.58142055 |
24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57904785 |
25 | cellular protein complex disassembly (GO:0043624) | 3.53947307 |
26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33478672 |
27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.32059768 |
28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21850748 |
29 | regulation of mast cell degranulation (GO:0043304) | 3.18298086 |
30 | response to peptidoglycan (GO:0032494) | 3.17307181 |
31 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.17013971 |
32 | protein complex disassembly (GO:0043241) | 3.16064454 |
33 | translational initiation (GO:0006413) | 3.08839084 |
34 | positive regulation of mast cell activation (GO:0033005) | 3.05103986 |
35 | viral protein processing (GO:0019082) | 3.04849590 |
36 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.03062413 |
37 | detection of other organism (GO:0098543) | 3.00257136 |
38 | virion assembly (GO:0019068) | 2.97476296 |
39 | macromolecular complex disassembly (GO:0032984) | 2.96036298 |
40 | response to host immune response (GO:0052572) | 2.95716716 |
41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.95716716 |
42 | ribosomal large subunit biogenesis (GO:0042273) | 2.93710242 |
43 | neutrophil activation (GO:0042119) | 2.93017977 |
44 | respiratory burst (GO:0045730) | 2.90258510 |
45 | granulocyte activation (GO:0036230) | 2.89257342 |
46 | detection of bacterium (GO:0016045) | 2.86801054 |
47 | protein maturation by protein folding (GO:0022417) | 2.85126023 |
48 | leukocyte aggregation (GO:0070486) | 2.84705779 |
49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81778572 |
50 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79510775 |
51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79158432 |
52 | negative regulation of interleukin-12 production (GO:0032695) | 2.78935918 |
53 | protein targeting to membrane (GO:0006612) | 2.78590260 |
54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.78208692 |
55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.78002086 |
56 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.77883276 |
57 | response to host (GO:0075136) | 2.75510426 |
58 | response to host defenses (GO:0052200) | 2.75510426 |
59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.75510426 |
60 | pentose metabolic process (GO:0019321) | 2.75098034 |
61 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.74681887 |
62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73057243 |
63 | regulation of leukocyte degranulation (GO:0043300) | 2.72036189 |
64 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.71621591 |
65 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.70100052 |
66 | regulation of defense response to virus by virus (GO:0050690) | 2.70022806 |
67 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67890126 |
68 | pentose-phosphate shunt (GO:0006098) | 2.66412646 |
69 | regulation of superoxide anion generation (GO:0032928) | 2.65784198 |
70 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.62501810 |
71 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.62476419 |
72 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.61157387 |
73 | cellular extravasation (GO:0045123) | 2.58318306 |
74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.55268619 |
75 | positive regulation of mast cell degranulation (GO:0043306) | 2.55268619 |
76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54882564 |
77 | immunoglobulin mediated immune response (GO:0016064) | 2.53248577 |
78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52347685 |
79 | detection of external biotic stimulus (GO:0098581) | 2.48872025 |
80 | chaperone-mediated protein transport (GO:0072321) | 2.47124018 |
81 | leukocyte degranulation (GO:0043299) | 2.45572576 |
82 | mitochondrial calcium ion transport (GO:0006851) | 2.45186945 |
83 | positive regulation of protein homooligomerization (GO:0032464) | 2.44553476 |
84 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.43880928 |
85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.42850753 |
86 | modulation by virus of host process (GO:0019054) | 2.42567844 |
87 | translation (GO:0006412) | 2.41774290 |
88 | myeloid cell activation involved in immune response (GO:0002275) | 2.41273766 |
89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.37703917 |
90 | regulation of mast cell activation (GO:0033003) | 2.37653235 |
91 | ATP synthesis coupled proton transport (GO:0015986) | 2.34831000 |
92 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.34831000 |
93 | detection of molecule of bacterial origin (GO:0032490) | 2.34274911 |
94 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.33747645 |
95 | cellular response to virus (GO:0098586) | 2.33038152 |
96 | pinocytosis (GO:0006907) | 2.32931401 |
97 | NIK/NF-kappaB signaling (GO:0038061) | 2.32218472 |
98 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.32170532 |
99 | lipoxygenase pathway (GO:0019372) | 2.31753507 |
100 | protein neddylation (GO:0045116) | 2.30585667 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.26130956 |
2 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.89722471 |
3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.86588005 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.53227110 |
5 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.35555124 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 2.11966660 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.11179768 |
8 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07125829 |
9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04706358 |
10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.00768358 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96384702 |
12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92363664 |
13 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92335883 |
14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92090793 |
15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89909028 |
16 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87255318 |
17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87235271 |
18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.76833083 |
19 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76761722 |
20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75581518 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72798649 |
22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.68193553 |
23 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.65779387 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 1.63364593 |
25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60337933 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59229139 |
27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.58670162 |
28 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58372816 |
29 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57817157 |
30 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.57295355 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56751075 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56013677 |
33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.55786062 |
34 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.55769529 |
35 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55555208 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55479115 |
37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55267130 |
38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49758256 |
39 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.49564313 |
40 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.49051319 |
41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.48439648 |
42 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48063451 |
43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47758437 |
44 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47259864 |
45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46195812 |
46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45057717 |
47 | MAF_26560356_Chip-Seq_TH2_Human | 1.42649548 |
48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40783284 |
49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40700512 |
50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39656442 |
51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36772687 |
52 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.36244353 |
53 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35443950 |
54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35297461 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34867566 |
56 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.33562786 |
57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33524321 |
58 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32417384 |
59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32065580 |
60 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.31813142 |
61 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31360017 |
62 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.30611283 |
63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30206944 |
64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29956662 |
65 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29450301 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27586633 |
67 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.27199254 |
68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26198280 |
69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25463644 |
70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25155254 |
71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25012626 |
72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24302602 |
73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23628887 |
74 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.23543662 |
75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23181975 |
76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23104850 |
77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22887007 |
78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20386704 |
79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19891934 |
80 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19721121 |
81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19210105 |
82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17551404 |
83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16340525 |
84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16315813 |
85 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.15802124 |
86 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14595028 |
87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13898980 |
88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13863455 |
89 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13621021 |
90 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13425248 |
91 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.13168651 |
92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12426248 |
93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11317305 |
94 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.10723940 |
95 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10514602 |
96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09911916 |
97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09665747 |
98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09398030 |
99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09176806 |
100 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09073339 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 3.91129120 |
2 | MP0003436_decreased_susceptibility_to | 3.43257696 |
3 | MP0005058_abnormal_lysosome_morphology | 3.33669438 |
4 | MP0008260_abnormal_autophagy | 2.97998104 |
5 | MP0001835_abnormal_antigen_presentation | 2.84296519 |
6 | MP0003303_peritoneal_inflammation | 2.78764335 |
7 | MP0003724_increased_susceptibility_to | 2.61368065 |
8 | MP0003191_abnormal_cellular_cholesterol | 2.59469042 |
9 | MP0005451_abnormal_body_composition | 2.42270205 |
10 | MP0009333_abnormal_splenocyte_physiolog | 2.39587775 |
11 | MP0005000_abnormal_immune_tolerance | 2.32902142 |
12 | MP0005025_abnormal_response_to | 2.31068337 |
13 | MP0003806_abnormal_nucleotide_metabolis | 2.30349907 |
14 | MP0009379_abnormal_foot_pigmentation | 2.22273148 |
15 | MP0002419_abnormal_innate_immunity | 2.19657354 |
16 | MP0005671_abnormal_response_to | 2.19155330 |
17 | MP0000685_abnormal_immune_system | 2.18063470 |
18 | MP0001800_abnormal_humoral_immune | 2.17655791 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.10922658 |
20 | MP0002723_abnormal_immune_serum | 2.07665102 |
21 | MP0002420_abnormal_adaptive_immunity | 2.04508519 |
22 | MP0009785_altered_susceptibility_to | 2.03467106 |
23 | MP0001819_abnormal_immune_cell | 2.02599735 |
24 | MP0002452_abnormal_antigen_presenting | 1.97771920 |
25 | MP0002398_abnormal_bone_marrow | 1.91110529 |
26 | MP0001790_abnormal_immune_system | 1.88866627 |
27 | MP0005387_immune_system_phenotype | 1.88866627 |
28 | MP0005083_abnormal_biliary_tract | 1.83499747 |
29 | MP0002132_abnormal_respiratory_system | 1.78873102 |
30 | MP0000858_altered_metastatic_potential | 1.78137414 |
31 | MP0006082_CNS_inflammation | 1.76417635 |
32 | MP0004947_skin_inflammation | 1.75009964 |
33 | MP0000716_abnormal_immune_system | 1.71370202 |
34 | MP0003763_abnormal_thymus_physiology | 1.69866391 |
35 | MP0002429_abnormal_blood_cell | 1.63870834 |
36 | MP0000343_altered_response_to | 1.63487233 |
37 | MP0002722_abnormal_immune_system | 1.61792387 |
38 | MP0000689_abnormal_spleen_morphology | 1.55424374 |
39 | MP0001845_abnormal_inflammatory_respons | 1.53271626 |
40 | MP0000703_abnormal_thymus_morphology | 1.53084816 |
41 | MP0010155_abnormal_intestine_physiology | 1.51404175 |
42 | MP0002877_abnormal_melanocyte_morpholog | 1.50284149 |
43 | MP0001533_abnormal_skeleton_physiology | 1.48962047 |
44 | MP0003866_abnormal_defecation | 1.48655327 |
45 | MP0002405_respiratory_system_inflammati | 1.45788295 |
46 | MP0009840_abnormal_foam_cell | 1.42614706 |
47 | MP0000490_abnormal_crypts_of | 1.41921804 |
48 | MP0003300_gastrointestinal_ulcer | 1.41425633 |
49 | MP0006036_abnormal_mitochondrial_physio | 1.35053544 |
50 | MP0003656_abnormal_erythrocyte_physiolo | 1.32936174 |
51 | MP0005501_abnormal_skin_physiology | 1.31408029 |
52 | MP0001853_heart_inflammation | 1.31217292 |
53 | MP0003172_abnormal_lysosome_physiology | 1.29207652 |
54 | MP0003123_paternal_imprinting | 1.27095590 |
55 | MP0008469_abnormal_protein_level | 1.26916329 |
56 | MP0003186_abnormal_redox_activity | 1.22319288 |
57 | MP0001348_abnormal_lacrimal_gland | 1.21322249 |
58 | MP0004957_abnormal_blastocyst_morpholog | 1.21184913 |
59 | MP0004185_abnormal_adipocyte_glucose | 1.20385681 |
60 | MP0009764_decreased_sensitivity_to | 1.19714092 |
61 | MP0009278_abnormal_bone_marrow | 1.18811247 |
62 | MP0003828_pulmonary_edema | 1.17905888 |
63 | MP0003705_abnormal_hypodermis_morpholog | 1.11210534 |
64 | MP0008004_abnormal_stomach_pH | 1.07831337 |
65 | MP0006035_abnormal_mitochondrial_morpho | 1.05907711 |
66 | MP0003183_abnormal_peptide_metabolism | 1.00894080 |
67 | MP0003075_altered_response_to | 1.00889918 |
68 | MP0000313_abnormal_cell_death | 0.99935175 |
69 | MP0009763_increased_sensitivity_to | 0.99921698 |
70 | MP0001545_abnormal_hematopoietic_system | 0.99126436 |
71 | MP0005397_hematopoietic_system_phenotyp | 0.99126436 |
72 | MP0009765_abnormal_xenobiotic_induced | 0.98626500 |
73 | MP0000465_gastrointestinal_hemorrhage | 0.98411594 |
74 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97848624 |
75 | MP0001727_abnormal_embryo_implantation | 0.97765254 |
76 | MP0002796_impaired_skin_barrier | 0.95845942 |
77 | MP0001663_abnormal_digestive_system | 0.95364299 |
78 | MP0004510_myositis | 0.95234471 |
79 | MP0002019_abnormal_tumor_incidence | 0.94602910 |
80 | MP0003453_abnormal_keratinocyte_physiol | 0.91935964 |
81 | MP0002396_abnormal_hematopoietic_system | 0.88345692 |
82 | MP0000609_abnormal_liver_physiology | 0.87032142 |
83 | MP0001851_eye_inflammation | 0.84533368 |
84 | MP0002998_abnormal_bone_remodeling | 0.83100922 |
85 | MP0001873_stomach_inflammation | 0.82926465 |
86 | MP0003693_abnormal_embryo_hatching | 0.81598033 |
87 | MP0005310_abnormal_salivary_gland | 0.80753972 |
88 | MP0005319_abnormal_enzyme/_coenzyme | 0.79488029 |
89 | MP0004381_abnormal_hair_follicle | 0.76576947 |
90 | MP0002653_abnormal_ependyma_morphology | 0.76457289 |
91 | MP0008874_decreased_physiological_sensi | 0.75424611 |
92 | MP0003111_abnormal_nucleus_morphology | 0.74489704 |
93 | MP0004233_abnormal_muscle_weight | 0.74107932 |
94 | MP0001730_embryonic_growth_arrest | 0.73239828 |
95 | MP0003566_abnormal_cell_adhesion | 0.72200831 |
96 | MP0000358_abnormal_cell_content/ | 0.71711114 |
97 | MP0000604_amyloidosis | 0.71316648 |
98 | MP0003448_altered_tumor_morphology | 0.68542249 |
99 | MP0003077_abnormal_cell_cycle | 0.68066128 |
100 | MP0004808_abnormal_hematopoietic_stem | 0.66874062 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of macrophages (HP:0004311) | 4.19005368 |
2 | Prolonged bleeding time (HP:0003010) | 4.14821708 |
3 | Recurrent abscess formation (HP:0002722) | 4.07867314 |
4 | Purpura (HP:0000979) | 4.07517668 |
5 | Eczematoid dermatitis (HP:0000976) | 4.05518165 |
6 | Recurrent bacterial skin infections (HP:0005406) | 3.99739645 |
7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.84286040 |
8 | Petechiae (HP:0000967) | 3.72177577 |
9 | Obstructive lung disease (HP:0006536) | 3.58200744 |
10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.58200744 |
11 | Epistaxis (HP:0000421) | 3.27212465 |
12 | Menorrhagia (HP:0000132) | 3.26753582 |
13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13052542 |
14 | Abnormal number of erythroid precursors (HP:0012131) | 3.03483879 |
15 | Gingival bleeding (HP:0000225) | 3.00377384 |
16 | Abnormal platelet volume (HP:0011876) | 3.00370575 |
17 | Myositis (HP:0100614) | 2.92242820 |
18 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87247203 |
19 | Pallor (HP:0000980) | 2.87090796 |
20 | Mediastinal lymphadenopathy (HP:0100721) | 2.87025247 |
21 | Encephalitis (HP:0002383) | 2.77046556 |
22 | Urticaria (HP:0001025) | 2.73316928 |
23 | Orchitis (HP:0100796) | 2.71267421 |
24 | Reticulocytopenia (HP:0001896) | 2.69688905 |
25 | Increased IgM level (HP:0003496) | 2.69647658 |
26 | Increased serum ferritin (HP:0003281) | 2.69105292 |
27 | Gastrointestinal infarctions (HP:0005244) | 2.68703661 |
28 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.66870462 |
29 | Increased intramyocellular lipid droplets (HP:0012240) | 2.64695745 |
30 | Increased mean platelet volume (HP:0011877) | 2.64683806 |
31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.64472748 |
32 | Macrocytic anemia (HP:0001972) | 2.60971825 |
33 | Abnormal platelet function (HP:0011869) | 2.59528980 |
34 | Impaired platelet aggregation (HP:0003540) | 2.59528980 |
35 | Hepatosplenomegaly (HP:0001433) | 2.55969299 |
36 | Increased muscle lipid content (HP:0009058) | 2.53170569 |
37 | Recurrent skin infections (HP:0001581) | 2.51497932 |
38 | Meningitis (HP:0001287) | 2.47333037 |
39 | Renal Fanconi syndrome (HP:0001994) | 2.45361150 |
40 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.41899170 |
41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.41899170 |
42 | Spontaneous hematomas (HP:0007420) | 2.40555310 |
43 | Hypertensive crisis (HP:0100735) | 2.34724698 |
44 | Progressive muscle weakness (HP:0003323) | 2.31857468 |
45 | Optic neuritis (HP:0100653) | 2.29815867 |
46 | Retrobulbar optic neuritis (HP:0100654) | 2.29815867 |
47 | Stomatitis (HP:0010280) | 2.27732262 |
48 | Recurrent fungal infections (HP:0002841) | 2.25888862 |
49 | Thrombocytosis (HP:0001894) | 2.25296451 |
50 | Cellulitis (HP:0100658) | 2.22469500 |
51 | Abnormal hemoglobin (HP:0011902) | 2.21758025 |
52 | Acute hepatic failure (HP:0006554) | 2.21001844 |
53 | Recurrent viral infections (HP:0004429) | 2.19338605 |
54 | Gastrointestinal inflammation (HP:0004386) | 2.18925135 |
55 | Abnormality of reticulocytes (HP:0004312) | 2.18003283 |
56 | Ragged-red muscle fibers (HP:0003200) | 2.16414014 |
57 | Inflammation of the large intestine (HP:0002037) | 2.12139508 |
58 | Respiratory difficulties (HP:0002880) | 2.10836884 |
59 | Increased IgE level (HP:0003212) | 2.10125960 |
60 | Paralysis (HP:0003470) | 2.09380701 |
61 | Abnormality of iron homeostasis (HP:0011031) | 2.07981089 |
62 | Increased hepatocellular lipid droplets (HP:0006565) | 2.07210730 |
63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07147832 |
64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07147832 |
65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07147832 |
66 | Rough bone trabeculation (HP:0100670) | 2.06985525 |
67 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.06896300 |
68 | Anorexia (HP:0002039) | 2.03936402 |
69 | Increased cerebral lipofuscin (HP:0011813) | 2.02091701 |
70 | Colitis (HP:0002583) | 2.01161825 |
71 | Hypochromic anemia (HP:0001931) | 2.00936469 |
72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99451035 |
73 | Episodic fever (HP:0001954) | 1.97807391 |
74 | Arterial thrombosis (HP:0004420) | 1.95595325 |
75 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95322728 |
76 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95322728 |
77 | Gingivitis (HP:0000230) | 1.94785614 |
78 | Vasculitis (HP:0002633) | 1.94560050 |
79 | Reticulocytosis (HP:0001923) | 1.93520620 |
80 | Vertebral compression fractures (HP:0002953) | 1.93121113 |
81 | Lipid accumulation in hepatocytes (HP:0006561) | 1.90906214 |
82 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.90328361 |
83 | Deep venous thrombosis (HP:0002625) | 1.90054625 |
84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88980083 |
85 | Microcytic anemia (HP:0001935) | 1.88839167 |
86 | Vacuolated lymphocytes (HP:0001922) | 1.87543573 |
87 | Exertional dyspnea (HP:0002875) | 1.86631587 |
88 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.86282105 |
89 | Abnormality of the common coagulation pathway (HP:0010990) | 1.85922455 |
90 | Progressive neurologic deterioration (HP:0002344) | 1.84762314 |
91 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.83750318 |
92 | Amyloidosis (HP:0011034) | 1.83530960 |
93 | Progressive external ophthalmoplegia (HP:0000590) | 1.83342205 |
94 | Polycythemia (HP:0001901) | 1.83163249 |
95 | Keratoconjunctivitis sicca (HP:0001097) | 1.82290568 |
96 | Panhypogammaglobulinemia (HP:0003139) | 1.82113179 |
97 | Chest pain (HP:0100749) | 1.80007906 |
98 | Hyperthyroidism (HP:0000836) | 1.78375875 |
99 | Hypergammaglobulinemia (HP:0010702) | 1.77946404 |
100 | Pustule (HP:0200039) | 1.77027170 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TESK2 | 3.52361134 |
2 | RIPK4 | 3.33548310 |
3 | NME2 | 3.14497463 |
4 | STK16 | 3.07097584 |
5 | MAP3K11 | 2.66563807 |
6 | PRPF4B | 2.47234438 |
7 | ERN1 | 2.38993644 |
8 | TRIB3 | 2.38068430 |
9 | MAP2K3 | 2.31725847 |
10 | GRK6 | 2.05945196 |
11 | SMG1 | 2.05076069 |
12 | MAP4K1 | 1.97979078 |
13 | IRAK3 | 1.93860642 |
14 | TESK1 | 1.88340305 |
15 | BLK | 1.82164307 |
16 | VRK2 | 1.72192674 |
17 | EIF2AK1 | 1.70229523 |
18 | IRAK4 | 1.70088780 |
19 | TAOK2 | 1.67614798 |
20 | CSK | 1.58153216 |
21 | LRRK2 | 1.57015411 |
22 | TYK2 | 1.52907631 |
23 | ZAP70 | 1.43435272 |
24 | BTK | 1.41822339 |
25 | SCYL2 | 1.40818613 |
26 | ARAF | 1.35190370 |
27 | SIK1 | 1.31280345 |
28 | ICK | 1.23356285 |
29 | FES | 1.18541123 |
30 | TAOK1 | 1.17200321 |
31 | TBK1 | 1.16553716 |
32 | PIM2 | 1.16456704 |
33 | BMX | 1.12279617 |
34 | DYRK1B | 1.08403665 |
35 | MAP3K1 | 1.01240200 |
36 | SYK | 0.97333300 |
37 | MAP3K3 | 0.93966071 |
38 | KSR2 | 0.92947593 |
39 | MAP3K6 | 0.90771552 |
40 | CDK19 | 0.87169093 |
41 | JAK3 | 0.87141442 |
42 | IKBKE | 0.87109325 |
43 | FGR | 0.87029320 |
44 | CSF1R | 0.84442698 |
45 | DYRK3 | 0.83097761 |
46 | MAP3K5 | 0.82879120 |
47 | FGFR4 | 0.82423097 |
48 | PAK4 | 0.81259727 |
49 | MATK | 0.80897620 |
50 | BCKDK | 0.80730627 |
51 | TNK2 | 0.78915492 |
52 | HCK | 0.78776344 |
53 | LYN | 0.78159592 |
54 | MAP3K12 | 0.77422372 |
55 | ILK | 0.75266276 |
56 | IRAK2 | 0.73363684 |
57 | IKBKB | 0.73007260 |
58 | JAK2 | 0.71719949 |
59 | MAP3K14 | 0.71692694 |
60 | PDPK1 | 0.69764934 |
61 | AURKA | 0.69091552 |
62 | MARK2 | 0.68292247 |
63 | KDR | 0.68260528 |
64 | EPHB1 | 0.67545025 |
65 | BRAF | 0.66335763 |
66 | ABL2 | 0.66008037 |
67 | CDK12 | 0.64171826 |
68 | DAPK3 | 0.63291654 |
69 | SRPK1 | 0.62778385 |
70 | PTK6 | 0.62300331 |
71 | MAP3K10 | 0.62131399 |
72 | MARK3 | 0.60859461 |
73 | RPS6KB2 | 0.60168287 |
74 | ITK | 0.58619474 |
75 | LCK | 0.58401238 |
76 | TLK1 | 0.58252131 |
77 | PAK1 | 0.56651894 |
78 | MAP2K4 | 0.54545446 |
79 | SIK3 | 0.54134872 |
80 | STK10 | 0.53781696 |
81 | RPS6KC1 | 0.53269299 |
82 | RPS6KL1 | 0.53269299 |
83 | PIM1 | 0.53047038 |
84 | TXK | 0.51866737 |
85 | LIMK1 | 0.50774692 |
86 | MAPK11 | 0.50767341 |
87 | PDK1 | 0.49568609 |
88 | MAP3K8 | 0.47491546 |
89 | CDK7 | 0.46905398 |
90 | RAF1 | 0.46692495 |
91 | MAP2K2 | 0.46243261 |
92 | PBK | 0.46181055 |
93 | STK4 | 0.45545025 |
94 | RET | 0.43698898 |
95 | BMPR2 | 0.41864916 |
96 | CDK4 | 0.39484595 |
97 | SIK2 | 0.38010092 |
98 | NME1 | 0.37443127 |
99 | PRKCD | 0.36617083 |
100 | PKN2 | 0.35143778 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.42399370 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93443913 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92450900 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85376357 |
5 | Proteasome_Homo sapiens_hsa03050 | 1.79536685 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79387218 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79057920 |
8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78922250 |
9 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72080225 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70211442 |
11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.68347401 |
12 | DNA replication_Homo sapiens_hsa03030 | 1.66567845 |
13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.65466455 |
14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.63557337 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59359620 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59291234 |
17 | Shigellosis_Homo sapiens_hsa05131 | 1.54057979 |
18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53306951 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.50153739 |
20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47147737 |
21 | Spliceosome_Homo sapiens_hsa03040 | 1.41536347 |
22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38434900 |
23 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.38332042 |
24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34876289 |
25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34259515 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.31986296 |
27 | Measles_Homo sapiens_hsa05162 | 1.25162591 |
28 | Apoptosis_Homo sapiens_hsa04210 | 1.23888425 |
29 | Allograft rejection_Homo sapiens_hsa05330 | 1.20659839 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20359628 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20273016 |
32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17998147 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17351185 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16934794 |
35 | Malaria_Homo sapiens_hsa05144 | 1.15252875 |
36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15079956 |
37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15038047 |
38 | Lysosome_Homo sapiens_hsa04142 | 1.15016550 |
39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14943134 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.12179836 |
41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11655644 |
42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.11294531 |
43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10788379 |
44 | Base excision repair_Homo sapiens_hsa03410 | 1.10717841 |
45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10685255 |
46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10539381 |
47 | Phagosome_Homo sapiens_hsa04145 | 1.10088219 |
48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09702766 |
49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09592230 |
50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08756088 |
51 | Salmonella infection_Homo sapiens_hsa05132 | 1.08359346 |
52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08173226 |
53 | Endocytosis_Homo sapiens_hsa04144 | 1.06441402 |
54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.03373103 |
55 | Platelet activation_Homo sapiens_hsa04611 | 1.02498286 |
56 | Mismatch repair_Homo sapiens_hsa03430 | 1.01492242 |
57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01484610 |
58 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01432800 |
59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00264888 |
60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98187705 |
61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97514267 |
62 | RNA polymerase_Homo sapiens_hsa03020 | 0.96194112 |
63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96138908 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95632741 |
65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94645748 |
66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94222205 |
67 | Influenza A_Homo sapiens_hsa05164 | 0.94111825 |
68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93969669 |
69 | Bladder cancer_Homo sapiens_hsa05219 | 0.91465911 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.89143701 |
71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86346300 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84287564 |
73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83402215 |
74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83323468 |
75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81532333 |
76 | Legionellosis_Homo sapiens_hsa05134 | 0.78101993 |
77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75390932 |
78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74727813 |
79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74375567 |
80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73207100 |
81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64880739 |
82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64146364 |
83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63565586 |
84 | Asthma_Homo sapiens_hsa05310 | 0.63302844 |
85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61026529 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60103210 |
87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59929934 |
88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56191346 |
89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54329954 |
90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54067283 |
91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50497688 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50293430 |
93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48150900 |
94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47178558 |
95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46319140 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.46214837 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45734128 |
98 | Alcoholism_Homo sapiens_hsa05034 | 0.44867875 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44460185 |
100 | Prion diseases_Homo sapiens_hsa05020 | 0.40950447 |